Clinical Trials
3 trialsNCT01226394 2026-04-06
ProphyloCHIP
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3 Completed
NCT05001282 2024-08-07
A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα)
Elucida Oncology
Phase 1/2 Terminated
NCT01834469 2014-10-15
OV-AP-ICG-IV
Jules Bordet Institute
Phase 1/2 Completed